Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an IL-17/IL-23 bispecific antibody for treating inflammation

Use of an IL-17/IL-23 bispecific antibody for treating inflammation

US Patent 9994634 · Granted Jun 12, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific antibody analogs comprising a common light chain, and methods of t2024
Tissue-homing peptide conjugates and methods of use thereof2024
Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and me2024
Methods of treating severe insulin resistance by interfering with glucagon recep2023
Pelvic leveler2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Tissue-homing peptide conjugates and methods of use thereof2023
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors2022
Methods of treatment using IL-23p19 monoclonal antibodies2022
Cartilage-homing peptide conjugates and methods of use thereof2021
Methods of treating severe insulin resistance by interfering with glucagon recep2021